# Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients

> **NCT06079827** · — · UNKNOWN · sponsor: **MaxWell Clinic, PLC** · enrollment: 43 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06079827
- **Lead sponsor:** MaxWell Clinic, PLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-22
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06079827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06079827, "Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06079827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*